Related Experiment Video
Updated: May 27, 2026

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
Published on: January 9, 2019
Contrast-Enhanced Ultrasound With Ultrasound Localization Microscopy for Differentiating Benign From Malignant Focal
Hang Li1, Xiaoyan Niu1, Hui Yang1
1Department of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
This study explored how a new imaging technique called ultrasound localization microscopy (ULM) could help doctors tell the difference between benign and malignant liver lesions. The researchers compared ULM with a commonly used method called contrast-enhanced ultrasound (CEUS). They found that ULM provided detailed vascular data, such as microvessel density and flow velocity, which were more accurate in identifying malignant lesions. When ULM was combined with CEUS, the diagnostic accuracy improved even further. The results suggest that ULM could be a valuable addition to current diagnostic tools, helping doctors make more precise decisions about liver lesions.
Area of Science:
- Medical imaging diagnostics
- Hepatology
- Contrast-enhanced ultrasound
Background:
Current methods for diagnosing focal liver lesions rely heavily on visual assessment of contrast-enhanced ultrasound (CEUS) images. While this approach provides useful information, it lacks quantitative metrics that could improve diagnostic accuracy. Prior research has shown that CEUS can distinguish lesion types based on vascular patterns, but limitations remain in differentiating benign from malignant cases. This gap motivated the investigation of ultrasound localization microscopy (ULM) as a potential enhancement. ULM captures detailed vascular parameters, such as microvessel density and flow velocity, which may offer more precise diagnostic insights. No prior work had resolved how ULM metrics compare to CEUS in diagnosing liver lesions. The uncertainty around ULM’s added value in clinical settings drove this study. Researchers aimed to determine if ULM could provide more reliable diagnostic information than CEUS alone. This study addresses the need for improved diagnostic tools in liver lesion evaluation.
Purpose Of The Study:
The study aimed to assess whether quantitative parameters from ULM could improve the differentiation of benign and malignant focal liver lesions compared to conventional CEUS. Researchers focused on evaluating the added diagnostic value of ULM metrics over visual assessment. The specific problem addressed was the lack of objective, quantitative measures in CEUS-based diagnosis. By analyzing ULM-derived vascular parameters, the study sought to identify reliable predictors of lesion malignancy. The motivation was to enhance diagnostic accuracy and reduce uncertainty in liver lesion classification. The authors proposed that ULM could provide more detailed vascular information than CEUS alone. The study’s goal was to determine if combining ULM and CEUS would improve diagnostic performance. This approach could lead to better clinical decision-making in liver lesion evaluation.
Main Methods:
The study used a prospective design involving patients with focal liver lesions who underwent both CEUS and ULM imaging. Blinded visual assessment of CEUS images was conducted independently of ULM data extraction. ULM parameters such as microvessel density and flow velocity were quantified for each lesion. Multivariate analysis was employed to identify independent predictors of malignancy. A logistic regression model was developed using ULM-derived variables. The diagnostic performance of CEUS, ULM, and their combination was evaluated using ROC analysis. Lesion classification was based on histopathology or clinical follow-up. The study compared the area under the curve (AUC) for each diagnostic approach.
Main Results:
Malignant lesions showed significantly different ULM parameters compared to benign ones, including higher microvessel density and flow velocity. The ULM model identified three independent predictors: microvessel density ratio, perfusion index, and mean microvessel diameter. The ULM model achieved an AUC of 0.855 for differentiating benign from malignant lesions. CEUS visual assessment had an AUC of 0.808, which was lower than the ULM model’s performance. Combining ULM and CEUS improved the AUC to 0.928, significantly better than CEUS alone (p < 0.001). The combined approach provided more accurate classification of lesion types. ULM metrics captured detailed vascular features not visible in CEUS images. These findings suggest that ULM adds diagnostic value beyond conventional methods.
Conclusions:
The authors proposed that ULM quantitative parameters effectively differentiate benign from malignant focal liver lesions. The ULM model outperformed CEUS visual assessment in diagnostic accuracy. Combining ULM and CEUS further improved lesion classification performance. The study demonstrated that ULM provides incremental diagnostic value beyond conventional methods. The combined approach offers more comprehensive vascular information for clinical use. These findings suggest ULM could serve as a complementary diagnostic tool in liver lesion evaluation. The authors emphasized the potential of ULM to enhance clinical decision-making. The results support the use of ULM as a promising addition to current diagnostic workflows.
Frequently Asked Questions
ULM improves lesion classification by capturing detailed vascular parameters like microvessel density and flow velocity.
ULM achieved an AUC of 0.855, outperforming CEUS’s AUC of 0.808 in differentiating benign from malignant lesions.
Higher microvessel density in malignant lesions helps distinguish them from benign ones, as shown by statistical significance in the study.
Perfusion index is an independent predictor in the ULM model, indicating vascular activity differences between lesion types.
The combined approach improved the AUC to 0.928, significantly better than CEUS alone (p < 0.001).
The authors proposed that ULM could serve as a complementary diagnostic tool to enhance clinical decision-making.

